Dabigatran (low dose) Strengths Weaknesses ↓ major bleeding than warfarin ↑ extracranial bleeding than warfarin in the elderly (age > 75 years)   ↓ tolerability compared to warfarin (dyspepsia)   Twice daily dosing

Table 2: Risk:Benefit Assessment of Low Dose Dabigatran